Anand P. Jillella

1 month ago | jamanetwork.com | Anand P. Jillella |Sandra Lee |Jessica K Altman |Selina M. Luger

Key PointsQuestion  Does the use of a standardized algorithm and expert support in the treatment of acute promyelocytic leukemia academic and community centers decrease induction mortality? Findings  In this nonrandomized clinical trial including 201 patients, 1-month mortality was reduced from an estimated 30% to 3% using specialist support and an algorithmically developed treatment plan.